Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Astec Lifesciences Ltd

Agro Chemicals | Small Cap

Astec Lifesciences Ltd Health Insights
Health Score : 4.06Health Score : 4.06

Astec Lifesciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strengths in solvency, driven by a manageable debt-to-equity ratio and reasonable interest coverage. However, it faces challenges in efficiency, particularly in inventory and receivables management. Growth metrics reveal a decline in revenue and operating profit, alongside a concerning trend in earnings per share. While asset growth remains strong, profitability is under pressure due to shrinking margins and returns. The financial ratios show strengths in book value per share and capital expenditure management, but weaknesses in adjusted earnings and dividend payouts. Overall, Astec Lifesciences exhibits financial resilience but needs to address declining profitability and efficiency to ensure sustainable growth.

Latest Report

View All
Audited Standalone Financial Results for the Quarter and Full Year Ending March 31, 2026

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Astec Lifesciences Ltd Health Insights
Health Score : 4.06Health Score : 4.06

Astec Lifesciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strengths in solvency, driven by a manageable debt-to-equity ratio and reasonable interest coverage. However, it faces challenges in efficiency, particularly in inventory and receivables management. Growth metrics reveal a decline in revenue and operating profit, alongside a concerning trend in earnings per share. While asset growth remains strong, profitability is under pressure due to shrinking margins and returns. The financial ratios show strengths in book value per share and capital expenditure management, but weaknesses in adjusted earnings and dividend payouts. Overall, Astec Lifesciences exhibits financial resilience but needs to address declining profitability and efficiency to ensure sustainable growth.

Latest Report

View All
Audited Standalone Financial Results for the Quarter and Full Year Ending March 31, 2026

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-1.36

Highly Undervalued

Industry Median

26.62

Highly Undervalued
Highly Undervalued

Small Cap Median

24.65

Highly Undervalued

P/E RATIO

-1.15

P/B RATIO

0.37

Neutral

Industry Median

3.32

Neutral
Neutral

Small Cap Median

3.13

Neutral

P/S RATIO

N/A

Neutral

Industry Median

1.80

Neutral
Neutral

Small Cap Median

1.46

Neutral

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

-2.57

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹69.06 as on Feb 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report27th Apr 26

Audited Standalone Financial Results for the Quarter and Full Year Ending March 31, 2026

UNDEFINED SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.80

The growth ratios present a mixed picture. While asset growth is strong, declines in revenue, operating profit, and earnings per share raise concerns about the company's ability to sustain growth. The company needs to address the factors contributing to these declines to ensure future growth prospects. Diversifying revenue streams and exploring new market opportunities could help revitalize growth.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate21.98-7.24-27.07-16.8117.59
Operating Profit Growth Rate37.5-50-107.791000-92.42
Earnings Per Share (EPS) Growth38.15-71.56-283.61187.16-39.63
Asset Growth Rate32.39.14-0.41-9.646.92
Net Income Growth Rate38.46-71.11-280.77187.23-40
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 5.60

The financial ratios present a mixed view. Strong book value per share and effective capital expenditure management are positive signs. However, low adjusted earnings per share and dividend payouts are areas of concern. Enhancing profitability and shareholder returns would improve overall financial health. Improving earnings quality and optimizing capital allocation can enhance shareholder value.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
GoodCash Earnings Per Share (Cash EPS)Good
ExcellentBook Value Per ShareExcellent
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)4513-23.5-68.5-35.91
Cash Earnings Per Share (Cash EPS)6230-5.5-45.5-16.36
Book Value Per Share198.5210185117.5177.27
Dividend Per Share (DPS)1.21.37000
Capital Expenditures (CapEx)103.9116.5135.115.94.8
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 2.30

The profitability ratios point to significant challenges. Declining gross profit, returns on capital, equity, and assets, along with shrinking operating and net margins, indicate a squeeze on profitability. Addressing these issues is crucial for improving financial performance. Focusing on cost control, revenue enhancement, and efficient asset utilization can help boost profitability.

WeakGross Profit MarginWeak
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin17.736.85-9.17-28.87-11.16
Return on Capital Employed (ROCE)228-4-13-5
Return on Equity (ROE)22.676.19-12.7-57.45-20.77
Return on Assets (ROA)17.177.87-0.62-7.49-0.53
Operating Margin22.7512.26-1.31-17.32-1.12
Net Margin13.294.14-10.26-35.43-18.08
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.00

The efficiency ratios indicate challenges in operational management. Low turnover ratios for inventory and receivables suggest that the company may be struggling to efficiently manage its working capital. High receivable days indicate that it takes a long time to collect payments, which can tie up cash. Addressing these inefficiencies is crucial for improving cash flow and overall operational performance.

PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.991.971.190.760.94
Inventory Turnover Ratio3.82.432.042.763.34
Receivables Turnover Ratio2.942.932.832.412.27
Days Sales in Inventory Ratio96.05150.21178.92132.25109.28
Receivable Days124.15124.57128.98151.45160.79
Capital Turnover Ratio1.711.460.80.741.02
01.

Inventory Turnover Ratio

02.

Receivables Turnover Ratio

03.

Days Sales in Inventory Ratio

04.

Receivable Days

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.00

The coverage ratios suggest limited ability to meet financial obligations. Further examination is needed to determine the company's capacity to cover interest and dividend payments. Strengthening the ability to meet financial obligations is crucial for maintaining financial stability and investor confidence. Improving earnings and cash flow management can enhance these coverage ratios.

AverageInterest Coverage RatioAverage
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio14.442.67-1.48-2.81-1.31
Equity Dividend Coverage Ratio33.338.33
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.09

The company's solvency position reflects a balanced financial structure. A low debt-to-equity ratio suggests the company relies more on equity than debt for financing, reducing financial risk. A good interest coverage ratio indicates the company can comfortably meet its interest obligations from its earnings. This suggests financial stability and a capacity to handle its debt obligations effectively, contributing to long-term sustainability.

GoodDebt RatioGood
ExcellentDebt to Equity RatioExcellent
ExcellentInterest Coverage RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio00.030.350.540.11
Debt to Equity Ratio00.030.541.170.12
Equity Ratio10.970.650.460.89
Debt To Asset Ratio00.010.20.320.05
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Interest Coverage Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 0.00

The company's liquidity position cannot be reliably assessed due to incomplete data. A comprehensive liquidity analysis requires a detailed review of current assets and liabilities, as well as cash flow management practices. Without sufficient information, it is not possible to determine the company's ability to meet its short-term obligations. Further investigation and data are needed to provide a meaningful assessment of Astec Lifesciences' liquidity.

AverageCurrent RatioAverage
AverageQuick RatioAverage
AverageCash RatioAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.070.971.040.980.92
Quick Ratio0.690.440.560.550.65
Cash Ratio0000.010.02
Operating Cash Flow Ratio0.050.140.02-0.02-0.16
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

Peer Comparison With 1 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Astec Lifesciences Ltd4.06-1.15Neutral-5.00-36.36-81.00
Management Assessment Summary
RedWeak Management

The management effectiveness of Astec Lifesciences Ltd is weak. While promoter holding is strong, the company has exhibited declining financial performance, particularly in sales and profit growth. The negative operating profit margins and net losses in recent quarters raise concerns about operational efficiency and profitability. Increased borrowings and a high cash conversion cycle further contribute to a negative outlook on management's strategic and operational capabilities.

Category Metric Value Assessment
PROS Promoter Holding 66.74% Strong confidence and alignment with shareholders.
CONS Sales Growth (3Y) -6% Declining revenue expansion.
Operating Profit Margin (TTM) -19% Deteriorating operational efficiency.
Net Profit (TTM) -104 Negative profitability.
ROCE (LY) -4% Poor capital utilization.
Debt/Equity Ratio (Sept 2024) 0.97 High leverage.
Cash Conversion Cycle (Mar 2024) 256 days Inefficient working capital management.
PoorFinancial Performance & GrowthPoor
WeakCapital Efficiency & ReturnsWeak
PoorFinancial Health & PrudencePoor
WeakStrategic & Operational IndicatorsWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
RedWeak Risk

The risk assessment for Astec Lifesciences is rated as Red due to the significant decline in profitability, indicated by negative profit margins and net losses, raises concerns about the company's financial stability. The increased borrowings and high debt-to-equity ratio further amplify the financial risk. Inefficient working capital management, reflected in the high cash conversion cycle, adds to the operational challenges.

WeakSegment performance volatilityWeak
01.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1067.01Bearish
  3. SMA 2066.87Bearish
  4. SMA 5066.58Bullish
  5. EMA 1066.96Bearish
  6. EMA 2066.91Bearish
  7. EMA 5066.79Bearish
  8. DEMA 1066.99Bearish
  9. DEMA 2067.04Bearish
  10. DEMA 5066.80Bearish
  11. TEMA 1066.94Bearish
  12. TEMA 2067.01Bearish
  13. TEMA 5066.98Bearish
  14. MACD0.09Bearish
  15. ADX16.90Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.61Neutral
  3. CCI-39.10Neutral
  4. ROC 90.32Bullish
  5. ROC 14-0.09Bearish
  6. ROC 25-0.63Bearish
  7. Stoch K32.27Neutral
  8. Stoch D36.52Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper67.61Neutral
  3. BB Middle66.87Neutral
  4. BB Lower66.12Neutral
  5. ATR1.09Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI57.67Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1066.75Bearish
  3. SMA 2066.84Bearish
  4. SMA 5066.57Bullish
  5. EMA 1066.77Bearish
  6. EMA 2066.70Bearish
  7. EMA 5066.72Bearish
  8. DEMA 1066.82Bearish
  9. DEMA 2066.79Bearish
  10. DEMA 5066.69Bearish
  11. TEMA 1066.76Bearish
  12. TEMA 2066.95Bearish
  13. TEMA 5066.50Bullish
  14. MACD0.07Bullish
  15. ADX21.12Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI49.04Neutral
  3. CCI-71.27Neutral
  4. ROC 9-0.02Bearish
  5. ROC 14-0.02Bearish
  6. ROC 252.41Bullish
  7. Stoch K24.82Neutral
  8. Stoch D28.49Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper67.41Neutral
  3. BB Middle66.84Neutral
  4. BB Lower66.26Neutral
  5. ATR1.33Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI46.53Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1066.71Bearish
  3. SMA 2066.07Bullish
  4. SMA 5066.42Bullish
  5. EMA 1066.58Bullish
  6. EMA 2066.59Bullish
  7. EMA 5066.42Bullish
  8. DEMA 1066.67Bearish
  9. DEMA 2066.51Bullish
  10. DEMA 5066.97Bearish
  11. TEMA 1066.81Bearish
  12. TEMA 2066.45Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.04Bullish
  15. ADX15.75Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI49.92Neutral
  3. CCI53.08Neutral
  4. ROC 9-0.89Bearish
  5. ROC 142.65Bullish
  6. ROC 25-3.55Bearish
  7. Stoch K58.16Neutral
  8. Stoch D58.37Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper67.68Neutral
  3. BB Middle66.07Neutral
  4. BB Lower64.45Neutral
  5. ATR1.86Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI61.11Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1066.21Bullish
  3. SMA 2067.22Bearish
  4. SMA 5066.81Bearish
  5. SMA 10064.96Bullish
  6. SMA 20067.54Bearish
  7. EMA 1066.78Bullish
  8. EMA 2066.67Bullish
  9. EMA 5066.12Bullish
  10. EMA 10066.20Bullish
  11. EMA 20068.67Bearish
  12. DEMA 1066.82Bearish
  13. DEMA 2066.99Bearish
  14. DEMA 5066.74Bullish
  15. DEMA 10064.81Bullish
  16. DEMA 20063.10Bullish
  17. TEMA 1066.79Bullish
  18. TEMA 2066.85Bearish
  19. TEMA 5067.47Bearish
  20. TEMA 10066.73Bullish
  21. TEMA 20062.12Bullish
  22. MACD0.22Bearish
  23. ADX15.87Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI51.01Neutral
  3. CCI-8.61Neutral
  4. ROC 14-4.46Bearish
  5. ROC 256.79Bullish
  6. Stoch K31.04Neutral
  7. Stoch D29.12Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper71.97Neutral
  3. BB Middle67.22Neutral
  4. BB Lower62.46Neutral
  5. ATR2.97Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI23.85Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2065.04Bullish
  3. SMA 5069.23Bearish
  4. EMA 2066.30Bullish
  5. EMA 5069.68Bearish
  6. DEMA 2065.43Bullish
  7. DEMA 5064.03Bullish
  8. TEMA 2067.32Bearish
  9. TEMA 5060.99Bullish
  10. MACD-0.40Bullish
  11. ADX14.22Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI48.58Neutral
  3. CCI-52.50Neutral
  4. ROC 147.18Bullish
  5. ROC 25-1.14Bearish
  6. Stoch K72.78Neutral
  7. Stoch D69.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper74.15Neutral
  3. BB Middle65.04Neutral
  4. BB Lower55.93Neutral
  5. ATR6.72Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI30.99Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 664.86Bullish
  3. SMA 1269.77Bullish
  4. SMA 2482.81Bearish
  5. EMA 667.33Bullish
  6. EMA 1270.02Bullish
  7. EMA 2471.58Bullish
  8. DEMA 666.32Bullish
  9. DEMA 1265.08Bullish
  10. DEMA 2474.75Bearish
  11. TEMA 669.00Bullish
  12. TEMA 1262.29Bullish
  13. TEMA 2466.61Bullish
  14. MACD7.78Bearish
  15. ADX26.29Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.00Neutral
  3. CCI22.01Neutral
  4. ROC 25-20.24Bearish
  5. ROC 50211.03Bullish
  6. Stoch K24.81Neutral
  7. Stoch D45.06Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper104.03Neutral
  3. BB Middle77.51Neutral
  4. BB Lower50.98Neutral
  5. ATR15.18Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI68.48Neutral